newsfilter
← Latest News
GlobeNewswire·

Keros Therapeutics Announces Preliminary Results of Tender Offer

LEXINGTON, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ("Keros" or the "Company") (NASDAQ:KROS), today announced the preliminary results of its cash tender offer (the "Tender Offer") to repurchase